Section Arrow
Quote
NXTS.NASDAQ
- Nexentis Technologies Inc.
Quotes are at least 15-min delayed:2026/09/03 11:40 EDT
Regular Hours
Last
 1.65
-0.07 (-4.07%)
Day High 
1.7 
Prev. Close
1.72 
1-M High
2.16 
Volume 
5.65K 
Bid
1.66
Ask
1.68
Day Low
1.65 
Open
1.68 
1-M Low
1.61 
Market Cap 
2.50M 
Currency 美元 
P/E 0.21 
%Yield -- 
10-SMA 1.81 
20-SMA 1.86 
50-SMA 2.54 
52-W High 58.751 
52-W Low 1.4301 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
8.49/--
Enterprise Value
2.74M
Balance Sheet
Book Value Per Share
1.31
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MOSMosaic Company (The)25.28-0.5-1.94%167.57PE
CTVACorteva88.385-1.585-1.76%54.53PE
FMCFMC Corp12.47-0.86-6.45%-- 
NTRNutrien Ltd80.41+0.12+0.15%16.25PE
ICLICL Group Ltd5.805-0.035-0.60%24.33PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.